Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 1FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Personal Satisfaction 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Cyclophosphamide 908Carboplatin 785Paclitaxel 739pembrolizumab 738Cisplatin 707Bevacizumab 705Gemcitabine 619Docetaxel 578Rituximab 548Radiotherapy 539Dexamethasone 510Nivolumab 485Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 357Pemetrexed 334Cytarabine 334Oxaliplatin 333Lenalidomide 327Prednisone 326fludarabine phosphate 315Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Has results × Golytely × Clear all
NCT03298945 2025-02-05

Comparative Effectiveness of Split-Dose Colonoscopy Bowel Preparation Regimens

VA Office of Research and Development

Phase 4 Completed
2,239 enrolled 15 charts
Gastrointestinal

Colorectal Neoplasms

NCT00687830 2017-05-17

CCF

The Cleveland Clinic

Phase 3 Completed
136 enrolled 6 charts
Gastrointestinal

Colonic Neoplasms, Personal Satisfaction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡